This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Nara Institute of Science and Technology, Universitè De Genève, University of Geneva. Active years: 2010-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 114 
1 out of 71 
1 out of 26 
Years Active: 2010-2014
Title: The Innovations of Pedro L. Herrera
Introduction
Pedro L. Herrera is a prominent inventor from Chene-Bourg, Switzerland, known for his significant contributions to the field of medical innovations, particularly in diabetes research. With a total of two patents to his name, he has developed groundbreaking solutions that have the potential to advance therapeutic approaches in managing diabetes mellitus.
Latest Patents
Herrera's latest patents include innovative uses of NOGO-A inhibitors and related methods. The focus of his invention is on Nogo-A antagonists, which are useful for controlling blood glucose and blood insulin levels in individuals. This invention specifically targets insulin secretion deficiencies and provides methods and pharmaceutical formulations aimed at treating diabetes mellitus. Additionally, one of his patents involves the creation of a diabetes model animal, a transgenic mouse that expresses human HB-EGF precursors in islet beta cells. This model allows for selective destruction of beta cells and enables researchers to screen and develop new medicines and therapeutic protocols for diabetes.
Career Highlights
Throughout his career, Pedro L. Herrera has made substantial contributions to scientific research and innovation. He has worked with esteemed institutions that include the University of Zurich and the University of Geneva. His work has garnered attention in the academic community, contributing to significant advancements in understanding diabetes and its treatments.
Collaborations
Collaboration has been a key aspect of Herrera's career. He has worked alongside notable colleagues such as Martin E. Schwab and Claire Bonal, sharing insights and expertise that have enriched his research and led to successful innovation outcomes.
Conclusion
Pedro L. Herrera exemplifies the spirit of innovation that drives progress in medical science. His patents reflect a commitment to improving patient care and outcomes for individuals suffering from diabetes. As he continues to push the boundaries of research, his contributions will undoubtedly leave a lasting impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile